within Pharmacolibrary.Drugs.ATC.A;

model A02BC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.02333333333333333,
    adminDuration  = 600,
    adminMass      = 0.03,
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Lansoprazole is a proton pump inhibitor (PPI) used to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollingerâ€“Ellison syndrome. Lansoprazole is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects, following single oral administration in fasting state.</p><h4>References</h4><ol><li><a href='https://dx.doi.org/10.1007/BF00713570'>10.1007/BF00713570</a> Main PK values were sourced from: Chiba, K, et al., Eur J Clin Pharmacol. 1993;44(1):79-83 (DOI provided). Minor interindividual variability may exist.</li></ol></body></html>",
    revisions = "<html><body><ul><li>03/06/2025 model generated from PK parameters and knowledge obtained by LLM gpt-4.1 and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BC03;
